Agilent Technologies acquires Advanced Analytical Technologies (AATI)

Agilent Technologies acquired Advanced Analytical Technologies (AATI) for approximately $268 million, a transaction completed in April 2018, structured as all cash.

Advanced Analytical Technologies (AATI) operates in Life Sciences and Applied Markets, is based in Ankeny, Iowa, USA. Advanced Analytical Technologies (AATI) makes capillary-electrophoresis systems, including the Fragment Analyzer, for automated analysis of nucleic acids, proteins, carbohydrates and small molecules across pharma, academic, diagnostics and applied markets.

AATI's CE technology complemented Agilent's microfluidics and separations portfolio and expanded its capabilities in genomics, metabolomics and proteomics quality analysis.

This acquisition is another great example of Agilent effectively deploying our capital to create value for our customers and our shareholders.Patrick Kaltenbach, President, Agilent Life Sciences and Applied Markets Group

Advisory firms were not disclosed for this transaction.

You're subscribed.

Thanks for signing up.